BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19903806)

  • 61. Does typing of human papillomavirus assist in the triage of women with repeated low-grade, cervical cytologic abnormalities?
    Kaufman RH; Adam E
    Gynecol Oncol; 1998 Sep; 70(3):317-8. PubMed ID: 9790780
    [No Abstract]   [Full Text] [Related]  

  • 62. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
    Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cervical cancer screening: state of the art.
    Singer A
    Baillieres Clin Obstet Gynaecol; 1995 Mar; 9(1):39-64. PubMed ID: 7600729
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Screening for cervical cancer in high-risk populations: DNA pap test or Hybrid Capture II test alone?
    Miranda Pereira SM; Castelo A; Makabe S; Utagawa ML; Di Loreto C; Sakamoto Maeda MY; Marques JA; Santoro CL; Filho AL; Das Dores GB
    Int J Gynecol Pathol; 2006 Jan; 25(1):38-41. PubMed ID: 16306782
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HPV testing in primary screening of older women.
    Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
    Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Development and validation of a new HPV genotyping assay based on next-generation sequencing.
    Yi X; Zou J; Xu J; Liu T; Liu T; Hua S; Xi F; Nie X; Ye L; Luo Y; Xu L; Du H; Wu R; Yang L; Liu R; Yang B; Wang J; Belinson JL
    Am J Clin Pathol; 2014 Jun; 141(6):796-804. PubMed ID: 24838323
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening.
    Coste J; Cochand-Priollet B; de Cremoux P; Le Galès C; Cartier I; Molinié V; Labbé S; Vacher-Lavenu MC; Vielh P;
    BMJ; 2003 Apr; 326(7392):733. PubMed ID: 12676841
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High-risk HPV DNA detection by Hybrid Capture II. An adjunctive test for mildly abnormal cytologic smears in women > or = 50 years of age.
    Lin CT; Tseng CJ; Lai CH; Hsueh S; Huang HJ; Law KS
    J Reprod Med; 2000 Apr; 45(4):345-50. PubMed ID: 10804494
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening.
    Kotaniemi-Talonen L; Malila N; Nieminen P; Anttila A; Tarkkanen J; Laurila P; Hakama M
    Int J Cancer; 2008 Dec; 123(12):2902-6. PubMed ID: 18792100
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Cervical cancer screening and the place of the HPV test in 2012].
    Bosch FX; Bergeron C
    Ann Pathol; 2012 Nov; 32(5 Suppl):S22-3. PubMed ID: 23127928
    [No Abstract]   [Full Text] [Related]  

  • 71. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reflex human papillomavirus testing: leave the cytology interpretation alone.
    Davey DD
    Cancer; 2003 Aug; 99(4):187-90. PubMed ID: 12925978
    [No Abstract]   [Full Text] [Related]  

  • 73. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.
    De Vivar AD; Dawlett M; Wang JP; Jack A; Gong Y; Staerkel G; Guo M
    Arch Pathol Lab Med; 2015 Feb; 139(2):219-24. PubMed ID: 25611104
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of human papillomavirus deoxyribonucleic acid assay and repeated cervical cytologic examination in the detection of cervical intraepithelial neoplasia among human immunodeficiency virus-infected women. Cervical Disease Study Group of the American Foundation for AIDS Research Community Based Clinical Trials Network.
    Cohn JA; Gagnon S; Spence MR; Harrison DD; Kluzak TR; Langenberg P; Brinson C; Stein A; Hellinger J;
    Am J Obstet Gynecol; 2001 Feb; 184(3):322-30. PubMed ID: 11228481
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY; Wu Z; Li T; Yu L; Zhang SK; Zhang X; Qu P; Sun P; Xi MR; Liu X; Liao G; Sun L; Zhang Y; Chen W; Qiao YL
    Cancer Prev Res (Phila); 2020 Feb; 13(2):163-172. PubMed ID: 31871224
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
    Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
    Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
    Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [HPV test replaces Pap test in Uppsala].
    Olovsson M; Aarnio R; Rezapour M; Segeblad B; Sjöö EL; Wilander E
    Lakartidningen; 2013 Mar 26-Apr 9; 110(13-14):695-6. PubMed ID: 23634626
    [No Abstract]   [Full Text] [Related]  

  • 80. Can papilloma virus testing be used to improve cervical cancer screening?
    Jenkins D; Sherlaw-Johnson C; Gallivan S
    Int J Cancer; 1996 Mar; 65(6):768-73. PubMed ID: 8631589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.